Current evidence shows limited benefit from additional immunotherapy in renal cell carcinoma patients previously treated with immune checkpoint inhibitors. Two large randomized trials yielded negative ...

These findings should inform public health policies aimed at guaranteeing access to effective combination therapies. Renal cell carcinoma (RCC) is one of the most common malignancies of the ...

Active surveillance may be an appropriate option for older patients and those with greater comorbidity burden and worse ...

Background: Thioredoxin reductase (Trx) has been implicated in activation of hypoxia-inducible factor-1α, which is overexpressed in > 85% of renal cell carcinomas (RCCs). We evaluated the safety ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

Researchers in Nikolaus Rajewsky's lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to map a tumor's cellular neighborhoods in 3D and identify potential targets ...

In order to better the area's cellular coverage and connectivity, Rancho Mirage announced the launch of an interactive cell phone coverage map on its Facebook page. This map was created in an ...

Receiving an initial diagnosis of renal cell carcinoma (RCC) is often an overwhelming experience for patients. As a result, they may struggle to retain the wealth of new information given to them at ...

SUMMIT, N.J. , April 15, 2025 /PRNewswire/ -- A first in human proof of concept phase I clinical study of VAS-101 (Vasceptor®; topical curcumin gel) in sickle cell disease (SCD) is underway.